MENU
STOK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Stoke Therapeutics (STOK) Earnings Date & Reports

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine... Show more

A.I. Advisor
published Earnings

STOK is expected to report earnings to fall 5.60% to -61 cents per share on March 11

Stoke Therapeutics STOK Stock Earnings Reports
Q4'25
Est.
$-0.61
Q3'25
Missed
by $0.07
Q2'25
Beat
by $0.10
Q1'25
Beat
by $1.82
Q4'24
Beat
by $0.37
The last earnings report on November 04 showed earnings per share of -64 cents, missing the estimate of -57 cents. With 1.34M shares outstanding, the current market capitalization sits at 1.49B.
View a ticker or compare two or three
STOK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. STOK showed earnings on November 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company, which engages in the research and development of treatments for genetic diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com